FrancophonIA/ELRC3.0 huggingface dataset:
English: In two trials conducted in older adolescents and adults, 95.6-97.5 % of vaccinees developed a protective level of antibodies, with geometric mean titres in these trials ranging from 535 - 793 IU/l.
Croatian: U dva ispitivanja provedena u starijih adolescenata i odraslih, 95,6-97,5% cijepljenih ispitanika razvilo je zaštitnu razinu protutijela, uz srednji geometrijski titar u ovim ispitivanjima od 535 IU/l do 793 IU/l.
English: Immunocompromised vaccinees (e.g. dialysis patients, transplant patients, AIDS Patients)
Croatian: Cijepljenje imunokompromitiranih osoba (npr. bolesnici na dijalizi, bolesnici nakon presađivanja organa, bolesnici sa AIDS-om)
English: • Inflammation of the eye which causes pain and redness
Croatian: • upala oka, koja uzrokuje bol i crvenilo
English: Date of last renewal: 17/03/2011
Croatian: Datum posljednje obnove odobrenja: 17. ožujka 2011.
English: In babies born very prematurely (at or before 28 weeks of gestation) longer gaps than normal between breaths may occur for 2-3 days after vaccination.
Croatian: U novorođenčadi koja su rođena znatno prije termina (u 28. tjednu trudnoće ili ranije) tijekom 2 do 3 dana nakon cijepljenja mogu se javljati dulje stanke između udaha nego što je uobičajeno.
English: Cumulative multiple excursions between 0°C and 2°C are also permitted as long as the total time between 0°C and 2°C does not exceed 72 hours.
Croatian: Kumulativna višekratna pohrana cjepiva na temperaturama između 0°C i 2°C također je dozvoljena, ukoliko ukupno vrijeme čuvanja na temperaturi između 0°C i 2°C nije dulje od 72 sata.
English: * produced in Saccharomyces cerevisiae (strain 2150-2-3) yeast by recombinant DNA technology.
Croatian: *proizvedeno u kvascu Saccharomyces cerevisiae (soj 2150-2-3) tehnologijom rekombinantne DNK.
English: The concomitant administration of pneumococcal conjugate vaccine (PREVENAR) given with hepatitis B vaccine using the 0, 1 and 6 and 0, 1, 2 and 12 month schedules has not been sufficiently studied.
Croatian: Istodobna primjena pneumokoknog konjugiranog cjepiva (PREVENAR) koje se daje s cjepivom protiv hepatitisa B prema rasporedu 0., 1. i 6. te 0., 1., 2. i 12. mjesec nije dovoljno ispitana.
English: It is recommended that the vaccine be administered in the schedules indicated.
Croatian: Preporučuje se provesti cijepljenje prema navedenim rasporedima.
English: As with other hepatitis B vaccines, the duration of the protective effect in healthy vaccinees is unknown at present.
Croatian: Kao i s drugim cjepivima protiv hepatitisa B, trajanje zaštitnog učinka u zdravih cijepljenih osoba za sada nije poznato.
English: Although the duration of the protective effect of a previous formulation of Merck's recombinant hepatitis B vaccine in healthy vaccinees is unknown, follow-up over 5-9 years of approximately 3,000 high-risk subjects given a similar plasma-derived vaccine has revealed no cases of clinically apparent hepatitis B infection.
Croatian: Premda trajanje zaštitnog učinka prethodne formulacije Merckovog rekombinantnog cjepiva protiv hepatitisa B u zdravih cijepljenih osoba nije poznato, tijekom praćenja u trajanju od 5-9 godina približno 3000 osoba s visokim rizikom koje su primile slično cjepivo dobiveno iz plazme nije bilo slučajeva klinički vidljive infekcije hepatitisom B.
English: Hepatocellular carcinoma is a serious complication of hepatitis B virus infection.
Croatian: Hepatocelularni karcinom ozbiljna je komplikacija infekcije virusom hepatitisa B.
English: In clinical trials, 96 % of 1,497 healthy infants, children, adolescents and adults given a 3 dose course of a previous formulation of Merck's recombinant hepatitis B vaccine developed a protective level of antibodies against hepatitis B virus surface antigen ( 10 IU/l).
Croatian: U kliničkim ispitivanjima, 96% od 1497 zdrave dojenčadi, djece, adolescenata i odraslih koji su primili ciklus od 3 doze prethodne formulacije Merckovog rekombinantnog cjepiva protiv hepatitisa B razvilo je zaštitnu razinu protutijela protiv površinskog antigena virusa hepatitisa B (10 IU/l).
English: Hold the syringe barrel and attach the needle by twisting in clockwise direction, until the needle fits securely on the syringe.
Croatian: Držite tijelo štrcaljke i spojite iglu okretanjem u smjeru kazaljke na satu, sve dok igla ne bude čvrsto spojena sa štrcaljkom.
English: This product contains natural rubber latex which may cause allergic reactions.
Croatian: Ovaj lijek sadrži prirodnu lateks gumu koja može uzrokovati alergijske reakcije.
English: Caution should be exercised when prescribing the vaccine to pregnant or breast-feeding women.
Croatian: Potreban je oprez kad se cjepivo propisuje trudnicama i dojiljama.
English: Sodium chloride, borax and water for injections.
Croatian: Natrijev klorid, boraks i voda za injekcije.
English: In case of a recent exposure to the hepatitis B virus, a first dose of HBVAXPRO together with the appropriate dose of immunoglobulin can be given.
Croatian: U slučaju nedavnog izlaganja virusu hepatitisa B, prva doza cjepiva HBVAXPRO može se primijeniti zajedno s odgovarajućom dozom imunoglobulina.
English: A number of factors have been observed to reduce the immune response to hepatitis B vaccines.
Croatian: Primijećeno je da velik broj čimbenika smanjuje imunološki odgovor na cjepiva protiv hepatitisa B.
English: For clinical or laboratory monitoring regarding immunocompromised individuals or individuals with known or presumed exposure to hepatitis B virus, see section 4.2.
Croatian: Za kliničko ili laboratorijsko praćenje imunokompromitiranih pojedinaca ili pojedinaca za koje se zna ili pretpostavlja da su bili izloženi virusu hepatitisa B, vidjeti dio 4.2.
English: Investigations Elevation of liver enzymes
Croatian: Pretrage povišenje jetrenih enzima
English: The vaccine should be inspected visually prior to administration for any foreign particulate matter and/or abnormal physical appearance.
Croatian: Prije primjene cjepivo je potrebno pregledati zbog stranih čestica i/ili promijenjenog fizičkog izgleda.
English: - In the case of unvaccinated or incompletely vaccinated individuals, additional doses should be given as in the recommended immunisation schedule.
Croatian: - U osoba koje nisu cijepljene ili nisu dovršile cijepljenje, dodatne doze treba primijeniti prema preporučenom rasporedu imunizacije.
English: In two infant trials using different dosing schedules and concomitant vaccines, the proportion of infants with protective levels of antibodies were 97.5 % and 97.2 % with geometric mean titres of 214 and 297 IU/l, respectively.
Croatian: U dva ispitivanja u dojenčadi pomoću različitih rasporeda doziranja i istodobno primijenjenih cjepiva, udio dojenčadi sa zaštitnom razinom protutijela iznosio je 97,5% sa srednjim geometrijskim titrom od 214 IU/l i 97,2% sa srednjim geometrijskim titrom od 297 IU/l.
English: Your doctor, pharmacist or nurse will inform you if a booster dose should be given.
Croatian: Liječnik, ljekarnik ili medicinska sestra obavijestit će Vas ako je potrebno docjepljivanje.
English: Fertility: HBVAXPRO has not been evaluated in fertility studies.
Croatian: Plodnost: HBVAXPRO nije ispitan u ispitivanjima plodnosti.
English: Date of first authorisation: 27/04/2001
Croatian: Datum prvog odobrenja: 27. travnja 2001.
English: Exceptionally, the vaccine may be administered subcutaneously in patients with thrombocytopaenia (diminution of blood platelets) or to persons at risk of haemorrhage.
Croatian: U iznimnim slučajevima, cjepivo se može primijeniti potkožno u bolesnika s trombocitopenijom (smanjen broj krvnih pločica) i osoba s rizikom od krvarenja.
English: This vaccine should be administered intramuscularly.
Croatian: Cjepivo se primjenjuje intramuskularno.
English: Development of an antibody titre against hepatitis B virus surface antigen (anti-HBsAg) equal to or greater than 10 IU/l measured 1 to 2 months after the last injection correlates with protection to hepatitis B virus infection.
Croatian: Razina titra protutijela protiv površinskog antigena virusa hepatitisa B (anti-HBsAg) jednaka ili veća od 10 IU/l mjerena 1 do 2 mjeseca nakon posljednje injekcije, korelira sa zaštitom od infekcije virusom hepatitisa B.
English: Some local vaccination schedules currently include recommendations for a booster dose.
Croatian: Neki lokalni kalendari cijepljenja trenutno uključuju preporuke za docjepljivanje (tzv. "booster" doza).
English: The following undesirable effects have been reported following the widespread use of the vaccine.
Croatian: Sljedeće nuspojave zabilježene su nakon široke primjene cjepiva.
English: • Skin reactions such as eczema, Rash, Itching, Hives and Skin blistering, Hair loss
Croatian: • kožne reakcije kao što je ekcem, osip, svrbež, koprivnjača i mjehuri po koži, ispadanje kose
English: In general, the adverse event profile reported with overdose was comparable to that observed with the recommended dose of HBVAXPRO.
Croatian: Općenito je profil nuspojava zabilježenih kod predoziranja bio usporediv s onim opaženim kod primjene preporučene doze cjepiva HBVAXPRO.
English: Before use, the syringe should be well shaken.
Croatian: Prije primjene štrcaljku treba dobro protresti.
English: Immunocompetent vaccinees
Croatian: Cijepljenje imunokompetentnih osoba
English: Do not use this vaccine after the expiry date which is stated on the label.
Croatian: Ovo cjepivo se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i naljepnici iza oznake "EXP".
English: Exceptionally, the vaccine may be administered subcutaneously in patients with thrombocytopaenia or bleeding disorders.
Croatian: U iznimnim se slučajevima cjepivo može primijeniti supkutano u bolesnika s trombocitopenijom ili poremećajima krvarenja.
English: Once the vial has been penetrated, the withdrawn vaccine should be used promptly, and the vial must be discarded.
Croatian: Nakon što se bočica probuši, izvučeno cjepivo treba odmah primijeniti, a bočica se mora baciti.
English: This vaccine may contain traces of formaldehyde and potassium thiocyanate, which are used during the manufacturing process.
Croatian: Cjepivo može sadržavati tragove formaldehida i kalijevog tiocijanata, koji se koriste tijekom postupka proizvodnje.
English: The vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg).
Croatian: Cjepivo izaziva stvaranje specifičnih humoralnih protutijela protiv površinskog antigena virusa hepatitisa B (anti-HBsAg).
English: Dosage recommendations for neonates born to mothers who are hepatitis B virus carriers
Croatian: Preporuke za doziranje u novorođenčadi majki koje nose virus hepatitisa B
English: Detailed information on this product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Croatian: Detaljnije informacije o ovom lijeku dostupne su na internetskoj stranici Europske agencije za lijekove http://www.ema.europa.eu.
English: In subjects in whom insufficient antibody titres are achieved after boosting, the use of alternative hepatitis B vaccines should be considered.
Croatian: U osoba u kojih se ne postigne zadovoljavajući titar protutijela nakon docjepljivanja, potrebno je razmotriti primjenu alternativnih cjepiva protiv hepatitisa B.
English: The accelerated schedule including the 12 month booster dose can be proposed.
Croatian: Može se predložiti ubrzani raspored koji uključuje docjepljivanje u 12. mjesecu.
English: Intramuscular use
Croatian: Intramuskularno
English: HBVAXPRO 10 micrograms is not indicated in this subset of paediatric population.
Croatian: HBVAXPRO 10 mikrograma nije indiciran u ove podskupine pedijatrijske populacije.
English: 1 single dose 0.5 ml pre-filled syringe without needle 10 single dose 0.5 ml pre-filled syringes without needle 20 single dose 0.5 ml pre-filled syringes without needle 50 single dose 0.5 ml pre-filled syringes without needle 1 single dose 0.5 ml pre-filled syringe with 1 separate needle 10 single dose 0.5 ml pre-filled syringes with 1 separate needle (for each syringe) 1 single dose 0.5 ml pre-filled syringe with 2 separate needles 10 single dose 0.5 ml pre-filled syringes with 2 separate needles (for each syringe) 20 single dose 0.5 ml pre-filled syringes with 2 separate needles (for each syringe) 50 single dose 0.5 ml pre-filled syringes with 2 separate needles (for each syringe)
Croatian: 1 jednodozna napunjena štrcaljka od 0,5 ml, bez igle 10 jednodoznih napunjenih štrcaljki od 0,5 ml, bez igle 20 jednodoznih napunjenih štrcaljki od 0,5 ml, bez igle 50 jednodoznih napunjenih štrcaljki od 0,5 ml, bez igle 1 jednodozna napunjena štrcaljka od 0,5 ml, sa 1 zasebnom iglom 10 jednodoznih napunjenih štrcaljki od 0,5 ml, sa 1 zasebnom iglom (za svaku štrcaljku) 1 jednodozna napunjena štrcaljka od 0,5 ml, sa 2 zasebne igle 10 jednodoznih napunjenih štrcaljki od 0,5 ml, sa 2 zasebne igle (za svaku štrcaljku) 20 jednodoznih napunjenih štrcaljki od 0,5 ml, sa 2 zasebne igle (za svaku štrcaljku) 50 jednodoznih napunjenih štrcaljki od 0,5 ml, sa 2 zasebne igle (za svaku štrcaljku)
English: - At birth, one dose of hepatitis B immunoglobulin (within 24 hours).
Croatian: - Odmah nakon rođenja, jedna doza imunoglobulina protiv hepatitisa B (unutar 24 sata).
English: The needle is attached by twisting in clockwise direction, until the needle fits securely on the syringe.
Croatian: Igla se spaja zakretanjem u smjeru kazaljke na satu, sve dok ne bude čvrsto spojena sa štrcaljkom.
English: Vascular disorders Hypotension, Vasculitis
Croatian: Krvožilni poremećaji hipotenzija, vaskulitis
English: The other ingredients are sodium chloride, borax and water for injections.
Croatian: Pomoćne tvari su natrijev klorid, boraks i voda za injekcije.
English: MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ BIOLOŠKIH DJELATNIH TVARI I PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: Tel: 8007 4433 (+356 99917558) malta_info@merck.com
Croatian: Τel: 8007 4433 (+356 99917558) malta_info@merck.com
English: Merck Sharp & Dohme Corp. Sumneytown Pike West POINT,
Croatian: Sumneytown Pike West POINT,
English: - Hepatitis B immunoglobulin should be given as soon as possible after exposure (within 24 hours).
Croatian: Nakon izlaganja potrebno je čim prije primijeniti imunoglobulin protiv hepatitisa B (unutar 24 sata).
English: HBVAXPRO should be administered as soon as possible after being removed from refrigeration.
Croatian: Nakon vađenja iz hladnjaka, HBVAXPRO se mora primijeniti čim je prije moguće.
English: In accordance with standard medical practice for hepatitis B vaccine administration, regular antibody testing should be done in hemodialysis patients.
Croatian: U skladu sa standardnom medicinskom praksom za primjenu cjepiva protiv hepatitisa B, u bolesnika na hemodijalizi potrebno je redovito određivati protutijela.
English: Individuals 16 years of age or more: 1 dose (1 ml) at each injection.
Croatian: Osobe u dobi od 16 ili više godina: 1 doza (1 ml) kod svake injekcije.
English: - concomitantly with other vaccines, using separate sites and syringes.
Croatian: - istodobno s drugim cjepivima, s time da se mora primijeniti na različito mjesto zasebnom štrcaljkom.
English: A course of vaccination should include at least three injections.
Croatian: Ciklus cijepljenja treba uključiti najmanje tri injekcije.
English: Paresthesia, Paralysis (including Bell's palsy, facial paralysis), Peripheral neuropathies (polyradiculoneuritis, Guillain Barre Syndrome), Neuritis (including optical neuritis), Myelitis (including transverse Myelitis), Encephalitis, Demyelinating disease of the central nervous system, Exacerbation of multiple sclerosis, Multiple sclerosis, Seizure, Headache, Dizziness, Syncope
Croatian: Poremećaji živčanog sustava parestezija, paraliza (uključujući Bellovu paralizu, facijalna paraliza), periferne neuropatije (poliradikuloneuritis, Guillain Barreov sindrom), neuritis (uključujući optički neuritis), mijelitis (uključujući transverzalni mijelitis), encefalitis, demijelinizirajuća bolest središnjeg živčanog sustava, egzacerbacija multiple skleroze, multipla skleroza, napadaji, glavobolja, omaglica, sinkopa
English: If these conditions exist, the product should not be administered.
Croatian: Ako su prisutne takve promjene, cjepivo se ne smije primijeniti.
English: The protective efficacy of a dose of hepatitis B immunoglobulin at birth followed by 3 doses of a previous formulation of Merck's recombinant hepatitis B vaccine has been demonstrated for neonates born to mothers positive for both hepatitis B virus surface antigen (HBsAg) and hepatitis B virus e antigen (HBeAg).
Croatian: Doza imunoglobulina protiv hepatitisa B pri rođenju uz naknadno 3 doze prethodne formulacije Merckovog rekombinantnog cjepiva protiv hepatitisa B pokazala je protektivnu djelotvornost kod novorođenčadi majki pozitivnih na površinski antigen virusa hepatitisa B (HBsAg) i antigen e virusa hepatitisa B (HBeAg).
English: As with other hepatitis B vaccines, in many instances, the causal relationship to the vaccine has not been established.
Croatian: Kao i s ostalim cjepivima protiv hepatitisa B, u mnogim slučajevima nije utvrđen uzročno-posljedični odnos s cjepivom.
English: However, HBVAXPRO is expected to have no or negligible influence on the ability to drive and use machines.
Croatian: Međutim, ne očekuje se da će HBVAXPRO utjecati ili će zanemarivo utjecati na sposobnost upravljanja vozilima i rada sa strojevima.
English: Those receiving the compressed regimen (0, 1, 2 months dosing schedule) must receive the 12 month booster to induce higher antibody titres.
Croatian: Osobe koje se cijepe prema ubrzanom režimu (raspored doziranja 0., 1., 2. mjesec) moraju se docijepiti ("booster" doza) u 12. mjesecu kako bi se postigli viši titri protutijela.
English: Use caution when vaccinating latex-sensitive individuals since the syringe plunger stopper and tip cap contain dry natural latex rubber that may cause allergic reactions.
Croatian: Potreban je oprez kad se cijepe pojedinci osjetljivi na lateks, budući da čep klipa štrcaljke i zaštita za vrh sadrže suhu prirodnu gumu od lateksa koja može prouzročiti alergijske reakcije.
English: Suspension for injection 1 single dose 0.5 ml vial 10 single doses 0.5 ml vials 1 sterile injection syringe with needle
Croatian: Suspenzija za injekciju 1 jednodozna bočica od 0,5 ml 10 jednodoznih bočica od 0,5 ml 1 sterilna štrcaljka za injekciju s iglom.
English: Immune system disorders Serum sickness, Anaphylaxis, Polyarteritis nodosa
Croatian: Poremećaji imunološkog sustava serumska bolest, anafilaksija, nodozni poliarteritis
English: Blood and the lymphatic system disorders Thrombocytopaenia, Lymphadenopathy
Croatian: Poremećaji krvi i limfnog sustava trombocitopenija, limfadenopatija
English: Infants receiving the compressed regimen (0, 1, 2 months dosing schedule) must receive the 12 month booster to induce higher antibody titres.
Croatian: Dojenčad koja se cijepi prema ubrzanom režimu (raspored doziranja 0., 1., 2. mjesec) mora se docijepiti ("booster" doza) u 12. mjesecu kako bi se postigli viši titri protutijela.
English: Pregnancy:
Croatian: Trudnoća:
English: Fatigue, Fever, Malaise, Influenza-like symptoms
Croatian: umor, vrućica, malaksalost, simptomi nalik gripi
English: Suspension for injection 1 single dose 1 ml vial
Croatian: Suspenzija za injekciju 1 jednodozna bočica od 1 ml
English: If you or your child forget one dose of HBVAXPRO 5 micrograms
Croatian: Ako ste Vi ili Vaše dijete zaboravili primiti jednu dozu cjepiva HBVAXPRO 5 mikrograma
English: Merck Sharp & Dohme B.V. Waaderweg 39, 2031 BN Haarlem The Netherlands
Croatian: Waaderweg 39, 2031 BN Haarlem Nizozemska
English: Use caution when vaccinating latex-sensitive individuals since the vial stopper contains dry natural latex rubber that may cause allergic reactions.
Croatian: Potreban je oprez kad se cijepe pojedinci osjetljivi na lateks, budući da čep bočice sadrži suhu prirodnu gumu od lateksa koja može prouzročiti alergijske reakcije.
English: Pack size of 1, 10, 20, 50.
Croatian: Veličine pakiranja: 1, 10, 20, 50.
English: General disorders and administration site conditions Local reactions (injection site): Transient soreness, Erythema, Induration
Croatian: Opći poremećaji i reakcije na mjestu primjene lokalne reakcije (na mjestu injiciranja): prolazna bolnost, eritem, induracija
English: Warnings and precautions The container of this vaccine contains latex rubber.
Croatian: Spremnik ovog cjepiva sadrži lateks-gumu.
English: The most common side effects seen are injection-site reactions: transient soreness, erythema, induration.
Croatian: Najčešće nuspojave su reakcije na mjestu primjene: prolazna bolnost, eritem, induracija.
English: There is no clinical data on the use of HBVAXPRO on pregnant women.
Croatian: Nema kliničkih podataka o primjeni cjepiva HBVAXPRO u trudnica.
English: HBVAXPRO can be used to complete a primary immunisation course or as a booster dose in subjects who have previously received another hepatitis B vaccine.
Croatian: HBVAXPRO se može primijeniti za dovršavanje ciklusa primarne imunizacije ili kao doza za docjepljivanje u osoba koje su prethodno primile drugo cjepivo protiv hepatitisa B.
English: 1 single dose 1 ml pre-filled syringe without needle 10 single dose 1 ml pre-filled syringes without needle 1 single dose 1 ml pre-filled syringe with 1 separate needle 10 single dose 1 ml pre-filled syringes with 1 separate needle (for each syringe) 1 single dose 1 ml pre-filled syringe with 2 separate needles 10 single dose 1 ml pre-filled syringes with 2 separate needles (for each syringe) 20 single dose 1 ml pre-filled syringes with 2 separate needles (for each syringe)
Croatian: 1 jednodozna napunjena štrcaljka od 1 ml, bez igle 10 jednodoznih napunjenih štrcaljki od 1 ml, bez igle 1 jednodozna napunjena štrcaljka od 1 ml, sa 1 zasebnom iglom 10 jednodoznih napunjenih štrcaljki od 1 ml, sa 1 zasebnom iglom (za svaku štrcaljku) 1 jednodozna napunjena štrcaljka od 1 ml, sa 2 zasebne igle 10 jednodoznih napunjenih štrcaljki od 1 ml, sa 2 zasebne igle (za svaku štrcaljku) 20 jednodoznih napunjenih štrcaljki od 1 ml, sa 2 zasebne igle (za svaku štrcaljku)
English: Pack size of 1 vial with syringe and needle.
Croatian: Veličina pakiranja od 1 bočice sa štrcaljkom i iglom.
English: Respiratory, thoracic and mediastinal disorders Bronchospasm-like symptoms
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja simptomi slični bronhospazmu
English: Pregnancy: There is no clinical data on the use of HBVAXPRO on pregnant women.
Croatian: Trudnoća: Nema kliničkih podataka o primjeni cjepiva HBVAXPRO u trudnica.
English: Individuals from birth through 15 years of age: 1 dose (0.5 ml) at each injection.
Croatian: Osobe u dobi od rođenja do 15 godina: 1 doza (0,5 ml) kod svake injekcije.
English: Rash, Alopecia, Pruritus, Urticaria, Erythema multiforme, Angioedema, Eczema Very rare (<1/10,000) Musculoskeletal, connective tissue and bone disorders Arthralgia, Arthritis, Myalgia, Pain in extremity
Croatian: Poremećaji kože i potkožnog tkiva osip, alopecija, svrbež, urtikarija, multiformni eritem, angioedem, ekcem Vrlo rijetko (<1/10 000) Poremećaji mišićno-koštanog sustava i vezivnog tkiva artralgija, artritis, mialgija, bolovi u ekstremitetima
English: A course of vaccination should include three injections:
Croatian: Ciklus cijepljenja mora uključivati najmanje tri injekcije:
English: The most common side effects seen are injection-site reactions: soreness, redness and hardening.
Croatian: Najčešće opažene nuspojave su reakcije na mjestu primjene: bolnost, crvenilo i otvrdnuće.
English: What you need to know before you receive HBVAXPRO 10 micrograms
Croatian: Što morate znati prije nego počnete primati HBVAXPRO 10 mikrograma